Ronald I. Meltzer
Directeur/Bestuurslid bij Sequella, Inc.
Profiel
Ronald I.
Meltzer is currently a Director at Sequella, Inc. and a Member-Washington Leadership Board at State University of New York at Buffalo Law School.
He formerly worked as a Principal at American University and as a Professor at State University of New York at Buffalo.
He holds a doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from New York University, and an undergraduate degree from The Ohio University.
Actieve functies van Ronald I. Meltzer
Bedrijven | Functie | Begin |
---|---|---|
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Directeur/Bestuurslid | - |
State University of New York at Buffalo Law School | Corporate Officer/Principal | 20-07-2011 |
Eerdere bekende functies van Ronald I. Meltzer
Bedrijven | Functie | Einde |
---|---|---|
American University | Corporate Officer/Principal | - |
State University of New York at Buffalo | Corporate Officer/Principal | - |
Opleiding van Ronald I. Meltzer
New York University | Graduate Degree |
The Trustees of Columbia University in The City of New York | Doctorate Degree |
The Ohio University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Health Technology |